HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae-Young Um Selected Research

Testosterone (Sustanon)

7/2019Correction: Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells.
10/2017Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells.
2/2017Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
1/2016Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae-Young Um Research Topics

Disease

57Neoplasms (Cancer)
05/2024 - 02/2003
23Inflammation (Inflammations)
08/2023 - 12/2002
23Obesity
01/2021 - 12/2003
18Neoplasm Metastasis (Metastasis)
12/2022 - 04/2016
14Cerebral Infarction
01/2009 - 01/2003
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2023 - 01/2016
8Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 08/2016
8Atopic Dermatitis (Atopic Eczema)
01/2019 - 01/2006
7Colonic Neoplasms (Colon Cancer)
03/2024 - 01/2007
7Body Weight (Weight, Body)
03/2024 - 01/2007
7Hepatocellular Carcinoma (Hepatoma)
09/2023 - 12/2016
7Multiple Myeloma
01/2022 - 02/2017
7Colitis
01/2017 - 09/2010
7Ototoxicity
07/2015 - 03/2007
6Lung Neoplasms (Lung Cancer)
09/2023 - 05/2016
6Breast Neoplasms (Breast Cancer)
08/2022 - 10/2011
6Carcinogenesis
01/2022 - 04/2016
6Anaphylaxis (Anaphylactic Shock)
04/2017 - 01/2006
6Necrosis
02/2017 - 08/2006
6Fatigue
02/2012 - 10/2005
5Melanoma (Melanoma, Malignant)
05/2024 - 01/2017
5Prostatic Neoplasms (Prostate Cancer)
02/2022 - 01/2015
5Weight Gain
01/2017 - 01/2008
5Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2010 - 01/2006
4Weight Loss (Weight Reduction)
03/2024 - 10/2010
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2023 - 08/2019
4Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2004
4Hypersensitivity (Allergy)
03/2011 - 01/2007
4Vascular Diseases (Vascular Disease)
01/2006 - 02/2003
3Cachexia
05/2024 - 03/2021
3Fever (Fevers)
10/2020 - 01/2010
3Hypoxia (Hypoxemia)
01/2019 - 11/2007
3Hypertension (High Blood Pressure)
05/2008 - 12/2004
3Pathologic Processes
01/2007 - 01/2003
2Muscular Atrophy (Muscle Atrophy)
05/2024 - 03/2024
2Atrophy
05/2024 - 03/2024
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2022 - 03/2020
2Hematologic Neoplasms (Hematological Malignancy)
02/2022 - 02/2017
2Hyperplasia
01/2022 - 06/2017

Drug/Important Bio-Agent (IBA)

23CytokinesIBA
02/2018 - 01/2003
16Proteins (Proteins, Gene)FDA Link
05/2024 - 10/2005
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 12/2002
12STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2022 - 02/2012
8Mitogen-Activated Protein KinasesIBA
03/2020 - 06/2015
8NF-kappa B (NF-kB)IBA
03/2020 - 01/2006
7Transcription Factors (Transcription Factor)IBA
03/2021 - 01/2008
7Dextran SulfateIBA
01/2017 - 09/2010
6p-Methoxy-N-methylphenethylamineIBA
04/2017 - 07/2007
5Caspase 3 (Caspase-3)IBA
10/2022 - 01/2007
5Vanillic AcidIBA
01/2020 - 10/2010
5DinitrofluorobenzeneIBA
01/2019 - 03/2011
5Immunoglobulin E (IgE)IBA
06/2017 - 04/2007
5InterleukinsIBA
04/2017 - 09/2007
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2008 - 01/2003
4Ethanol (Ethyl Alcohol)IBA
12/2021 - 02/2011
4Phosphotransferases (Kinase)IBA
07/2021 - 02/2009
4Conditioned Culture MediaIBA
03/2021 - 01/2019
4Testosterone (Sustanon)FDA Link
07/2019 - 01/2016
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2019 - 02/2017
4Oxidoreductases (Dehydrogenase)IBA
01/2019 - 10/2005
4AntioxidantsIBA
12/2017 - 07/2008
4CadmiumIBA
01/2013 - 07/2008
4Glucose (Dextrose)FDA LinkGeneric
04/2012 - 10/2005
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 12/2008
4Genetic Markers (Genetic Marker)IBA
05/2008 - 01/2004
3Cisplatin (Platino)FDA LinkGeneric
05/2024 - 03/2007
3Cholestenone 5 alpha-Reductase (5 alpha-Reductase)IBA
10/2022 - 01/2018
3ChemokinesIBA
08/2022 - 01/2009
3dehydroabietylamineIBA
08/2022 - 07/2021
3IsoflavonesIBA
04/2022 - 01/2018
3CholesterolIBA
04/2022 - 08/2019
3ginkgolide CIBA
12/2021 - 11/2020
3bergamottinIBA
03/2021 - 10/2016
3LDL CholesterolIBA
01/2021 - 01/2008
3Matrix Metalloproteinases (MMPs)IBA
07/2020 - 06/2016
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2020 - 01/2013
3beta-lapachoneIBA
01/2019 - 01/2017
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2018 - 04/2012
3embelinIBA
01/2018 - 01/2013
3ResveratrolIBA
12/2017 - 02/2016
3chrysophanic acidIBA
02/2017 - 09/2010
3Dinitrochlorobenzene (DNCB)IBA
02/2017 - 07/2012
3Triglycerides (Triacylglycerol)IBA
01/2016 - 06/2010
3Histamine (Histamine Dihydrochloride)FDA Link
05/2013 - 04/2007
3Interleukin-1 (Interleukin 1)IBA
02/2013 - 07/2003
3Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2011 - 07/2003
3AngiotensinogenIBA
05/2008 - 01/2003
3Urea (Carbamide)FDA LinkGeneric
08/2006 - 10/2005
3NitrogenIBA
08/2006 - 10/2005
3Apolipoproteins E (ApoE)IBA
06/2005 - 01/2003
3ApolipoproteinsIBA
06/2005 - 01/2003
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2024 - 09/2007
2FlavonoidsIBA
03/2024 - 12/2017
2Telomerase (Telomerase Reverse Transcriptase)IBA
08/2023 - 01/2020
2brassininIBA
02/2023 - 07/2021
2fangchinoline (limacine)IBA
12/2022 - 01/2022
2CXC ChemokinesIBA
11/2022 - 07/2020

Therapy/Procedure

17Therapeutics
05/2024 - 01/2006
6Traditional Medicine (Folk Remedies)
01/2023 - 01/2007
2Drug Therapy (Chemotherapy)
05/2024 - 03/2007